Cargando…

Small round tumour cells (CD38, CD 79a positive) in the adrenal gland

Detalles Bibliográficos
Autores principales:	Nigam, L.A., Vanikar, A.V., Kanodia, K.V., Patel, R.D., Suthar, K.S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633744/ https://www.ncbi.nlm.nih.gov/pubmed/29021967 http://dx.doi.org/10.1016/j.eucr.2017.09.009

Ejemplares similares

Clinicopathological Study of Males with Lupus Nephritis: Pathologist's Experience at a Tertiary-Care Center
por: Patel, Rashmi D., et al.
Publicado: (2022)

Collapsing Glomerulopathy- A Troublemaker for the Renal Allograft: Lessons Learnt
por: Kanodia, K. V., et al.
Publicado: (2017)

Giant lipoma of the adrenal gland: a case report
por: Patel, Rashmi D, et al.
Publicado: (2011)

Membranous Nephropathy With MPO-ANCA-Associated Crescentic GN
por: Kanodia, Kamal, et al.
Publicado: (2014)

Pediatric Renal Biopsies in India: A Single-Centre Experience of Six Years
por: Kanodia, Kamal V., et al.
Publicado: (2015)

Primary Tubulovillous Adenocarcinoma of Renal Pelvis: An Unusual Genitourinary Tumor
por: Suthar, Kamlesh., et al.
Publicado: (2018)

Invasive fungal infections in renal transplant patients: a single center study
por: Patel, Minaxi H., et al.
Publicado: (2017)

High prevalence of chronic kidney disease in a semi-urban population of Western India
por: Trivedi, Hargovind, et al.
Publicado: (2016)

Abstract 79: Adrenal insufficiency in the elderly population
por: Joseph, Neal, et al.
Publicado: (2022)

Phenotyping and Target Expression Profiling of CD34(+)/CD38(−) and CD34(+)/CD38(+) Stem- and Progenitor cells in Acute Lymphoblastic Leukemia
por: Blatt, Katharina, et al.
Publicado: (2018)

Preclinical anti-tumour activity of HexaBody-CD38, a next-generation CD38 antibody with superior complement-dependent cytotoxic activity
por: Hiemstra, Ida H., et al.
Publicado: (2023)

Peripheral T-Cell Lymphoma with Aberrant Expression of CD19, CD20, and CD79a: Case Report and Literature Review
por: Matnani, Rahul G., et al.
Publicado: (2013)

Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells
por: He, Xiaocui, et al.
Publicado: (2018)

Expression of interferon-γ in human adrenal gland and kidney tumours
por: Li, Q, et al.
Publicado: (2007)

Anti‐CD22 and anti‐CD79b antibody‐drug conjugates preferentially target proliferating B cells
por: Fuh, Franklin K, et al.
Publicado: (2017)

Clinicopathological significance of CD79a expression in classic Hodgkin lymphoma
por: Sakatani, Akio, et al.
Publicado: (2020)

S79. CAR strategies in solid tumours
por: Rossig, C
Publicado: (2014)

CD38 in Neurodegeneration and Neuroinflammation
por: Guerreiro, Serge, et al.
Publicado: (2020)

CD38 in Advanced Prostate Cancers
por: Guo, Christina, et al.
Publicado: (2021)

Inflammatory myofibroblastic tumour arising in the adrenal gland: a case report
por: Tran-Dang, My-Anh, et al.
Publicado: (2014)

Possible role of CD22, CD79b and CD20 expression in distinguishing small lymphocytic lymphoma from chronic lymphocytic leukemia
por: Jovanovic, Danijela, et al.
Publicado: (2014)

Interferon gamma selectively inhibits very primitive CD342+CD38- and not more mature CD34+CD38+ human hematopoietic progenitor cells
Publicado: (1994)

P871: ISB 1442, A FIRST-IN-CLASS CD38 AND CD47 BISPECIFIC ANTIBODY INNATE CELL MODULATOR FOR THE TREATMENT OF CD38 POSITIVE HEMATOLOGICAL MALIGNANCIES
por: Grandclement, C., et al.
Publicado: (2022)

CD38 and Anti-CD38 Monoclonal Antibodies in AL Amyloidosis: Targeting Plasma Cells and beyond
por: Roccatello, Dario, et al.
Publicado: (2020)

Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad?
por: Plesner, Torben, et al.
Publicado: (2020)

CD79B and MYD88 Mutations in Splenic Marginal Zone Lymphoma
por: Trøen, Gunhild, et al.
Publicado: (2013)

Human CD79b(+) neutrophils in the blood are associated with early-stage melanoma
por: Meyer, Melissa A., et al.
Publicado: (2023)

United we stand: Double targeting of CD79B and CD20 in diffuse large B‐cell lymphoma
por: Tarantelli, Chiara, et al.
Publicado: (2022)

Compromised antigen binding and signaling interfere with bispecific CD19 and CD79a chimeric antigen receptor function
por: Leung, Isabel, et al.
Publicado: (2022)

P1237: PRELIMINARY RESULTS OF A PHASE Ⅱ STUDY OF ZANUBRUTINIB COMBINED WITH IMMUNOCHEMOTHERAPY IN PATIENTS WITH CD79A/CD79B-MUTANT DIFFUSE LARGE B-CELL LYMPHOMA
por: Yan, Z., et al.
Publicado: (2022)

Everolimus for the treatment of CD20+ diffuse large B-cell lymphoma in a renal allograft recipient
por: Kute, V. B., et al.
Publicado: (2012)

Enrichment of T-cell proliferation and memory gene signatures of CD79A/CD40 costimulatory domain potentiates CD19CAR-T cell functions
por: Ung, Socheatraksmey, et al.
Publicado: (2022)

Responses of CD27(+)CD38(+) plasmablasts, and CD24(hi)CD27(hi) and CD24(hi)CD38(hi) regulatory B cells during primary dengue virus 2 infection
por: Lei, Chenshuang, et al.
Publicado: (2021)

The role of CD38 in HIV infection
por: Lu, Liqi, et al.
Publicado: (2021)

Targeting CD38 for acute leukemia
por: Zhong, Xushu, et al.
Publicado: (2022)

CD38, CD157, and RAGE as Molecular Determinants for Social Behavior
por: Higashida, Haruhiro, et al.
Publicado: (2019)

EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma
por: Chemlal, Djamila, et al.
Publicado: (2023)

Decreased levels of T follicular helper (CD4+CXCR5+) cells and CD27+CD38+ and CD27+CD38− B cells in ankylosing spondylitis patients correlate with markers of inflammation
por: Lejon, Kristina, et al.
Publicado: (2022)

Deficit of circulating CD19(+)CD24(hi)CD38(hi) regulatory B cells in severe aplastic anaemia
por: Zaimoku, Yoshitaka, et al.
Publicado: (2020)

Influences of Age and Sex on the Effect of Hydrocortisone upon the Ehrlich Tumour and the Adrenal Gland
por: Takeuchi, Jun, et al.
Publicado: (1965)

Cannot write session to /tmp/vufind_sessions/sess_ch3ekcvjftv6hdjp42g4h19a7k